Yung‐Jue Bang

Researcher Next ID · RN-005677

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Gastric Cancer Management and Outcomes

Colorectal Cancer Treatments and Studies

HER2/EGFR in Cancer Research

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30445-9
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
JAMA Oncology · 2018 · https://doi.org/10.1001/jamaoncol.2018.0013
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1406766
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1003825
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(10)61121-x

No projects listed.